A randomised crossover trial of clinical algorithm for oxygen saturation targeting in preterm infants with frequent desaturation episodes.
Alexandra Clarke, Emma Yeomans, Kristy Elsayed...
https://pubmed.ncbi.nlm.nih.gov/25531240/Actively Recruiting
Led by Hospital Universitario 12 de Octubre · Updated on 2024-04-18
60
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating customized nasal masks made by 3D printing for non-invasive ventilation NIV in premature infants weighing less than 1500 grams. The study aims to compare the time these infants maintain blood oxygen saturation SatO2 below 85% using the 3D printed mask versus a traditional mask. Secondary goals include assessing apnea-related events like bradycardias, cardiorespiratory arrests, resuscitation needs, nasal skin injuries, pain control requirements, and parental satisfaction. Premature infants who need NIV will receive both the customized 3D printed mask and the traditional mask alternately every 4 hours, serving as their own control. The maximum study period is 7 days. This crossover design allows direct comparison of the two mask types within the same infant. The customized mask is tailored to each infants nose anatomy to potentially improve ventilation and comfort. During the study, infants will be closely monitored for oxygen levels, heart rate events, skin condition on the nose, and pain using scoring scales. Researchers will also record any need for cardiopulmonary resuscitation. Parents perceptions and satisfaction with the masks will be collected. The study is sponsored by Hospital Universitario 12 de Octubre and includes infants up to 30 days old who have been on NIV for less than 3 days before enrollment.
CONDITIONS
Clinical Trial for the Evaluation of Customized 3D Printed NIV Nasal Masks in Premature Infants
M
María Teresa Moral Pumarega
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Hospital Universitario 12 de Octubre
Lead Sponsor
ISCIII
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 7 days
Participants receive customized 3D printed nasal masks and traditional masks alternately during non-invasive ventilation to assess efficacy and safety.
Alternating mask application every 4 hours over the study period
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Alexandra Clarke, Emma Yeomans, Kristy Elsayed...
https://pubmed.ncbi.nlm.nih.gov/25531240/David G Sweet, Virgilio P Carnielli, Gorm Greisen...
https://pubmed.ncbi.nlm.nih.gov/36863329/Jia-Jun Xu, Yu-Jia Luo, Jin-Hua Wang...
https://pubmed.ncbi.nlm.nih.gov/30796731/Kelvin Duong, Joel Glover, Alexander C Perry...
https://pubmed.ncbi.nlm.nih.gov/33569497/Khaled Hadeed, Yves Dulac, Philippe Acar
https://pubmed.ncbi.nlm.nih.gov/27321706/Sangchul Roh, Dishit P Parekh, Bhuvnesh Bharti...
https://pubmed.ncbi.nlm.nih.gov/28590510/Ola Didrik Saugstad, Dagfinn Aune
https://pubmed.ncbi.nlm.nih.gov/24247112/Hui Zhao, Guanfeng Lin, Yong Hae Seong...
https://pubmed.ncbi.nlm.nih.gov/29219007/David G Sweet, Virgilio Carnielli, Gorm Greisen...
https://pubmed.ncbi.nlm.nih.gov/30974433/Nirveek Bhattacharjee, Cesar Parra-Cabrera, Yong Tae Kim...
https://pubmed.ncbi.nlm.nih.gov/29656459/Hospital Universitario 12 de Octubre
Lead Sponsor
ISCIII
Collaborating Sponsor